Bristol-Myers Squibb Research & Development, 5 Research Parkway, PO Box 5100, Wallingford, CT 06492, USA.
Bioorg Med Chem Lett. 2013 Jan 1;23(1):203-8. doi: 10.1016/j.bmcl.2012.10.117. Epub 2012 Nov 5.
As part of the SAR profiling of the indole-oxoacetic piperazinyl benzamide class of HIV-1 attachment inhibitors, substitution at the C7 position of the lead 4-fluoroindole 2 with various 5- and 6-membered heteroaryl moieties was explored. Highly potent (picomolar) inhibitors of pseudotyped HIV-1 in a primary, cell-based assay were identified and select examples were shown to possess nanomolar inhibitory activity against M- and T-tropic viruses in cell culture. These C7-heteroaryl-indole analogs maintained the ligand efficiency (LE) of 2 and were also lipophilic efficient as measured by LLE and LELP. Pharmacokinetic studies of this class of inhibitor in rats showed that several possessed substantially improved IV clearance and half-lives compared to 2. Oral exposure in the rat correlated with membrane permeability as measured in a Caco-2 assay where the highly permeable 1,2,4-oxadiazole analog 13 exhibited the highest exposure.
作为 SAR 分析的一部分,对 HIV-1 附着抑制剂的吲哚-氧代乙酸哌嗪基苯甲酰胺类进行了研究,在先导化合物 4-氟吲哚 2 的 C7 位置上用各种 5- 和 6-元杂芳基取代基进行了探索。在原代细胞测定中,鉴定出对假型 HIV-1 具有高度活性(皮摩尔级)的抑制剂,并且选择的实例显示在细胞培养中对 M 和 T 嗜性病毒具有纳摩尔抑制活性。这些 C7-杂芳基-吲哚类似物保持了 2 的配体效率(LE),并且通过 LLE 和 LELP 测量也具有亲脂性效率。该类抑制剂在大鼠中的药代动力学研究表明,与 2 相比,几种抑制剂的 IV 清除率和半衰期有了显著提高。在大鼠中的口服暴露与在 Caco-2 测定中测量的膜通透性相关,其中高渗透性 1,2,4-噁二唑类似物 13 表现出最高的暴露量。